Regorafenib-pembrolizumab vs. TACE/TARE in Intermediate Stage HCC Beyond Up-to-7
Clinical trial NCT04777851 · TERMINATED
Trial details
- NCT number
- NCT04777851
- Sponsor
- Translational Research in Oncology
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-11
- Primary completion
- 2026-02-26
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.